Table 2 Clinical characteristics of CAD patients
From: The GPIIIA PlA2 polymorphism is associated with an increased risk of cardiovascular adverse events
Variable | PlA1 (n = 300) | PlA2 (n = 100) | p Value |
|---|---|---|---|
Age | 60 ± 10 | 62.1 ± 8.6 | 0.72 |
Male sex (%) | 90 | 81 | 0.03 |
Hypertension (%) | 56 | 57 | 0.82 |
Diabetes (%) | 29.3 | 19.4 | 0.11 |
Smoking (%) | 58.6 | 53.8 | 0.45 |
Dyslipidemia (%) | 55.2 | 53.8 | 0.81 |
Obesity (%) | 9.5 | 7.7 | 0.89 |
Family history of CAD (%) | 38.2 | 33.4 | 0.37 |
Previous AMI (%) | 10.9 | 15.4 | 0.35 |
Previous PCI (%) | 10.9 | 15.4 | 0.35 |
Previous CABG (%) | 9.1 | 3.8 | 0.15 |
LVEF prior to PCI, mean ± SD | 47 ± 10 | 51 ± 8 | 0.06 |